The Enterprise Value as of December 2025 (TTM) for Glenmark Life Sciences Limited (GLS.NS) is 128.77B

According to Glenmark Life Sciences Limited’s latest financial reports and current stock price. The company's current Enterprise Value is 128.77B. This represents a change of 55.79% compared to the average of 82.66B of the last 4 quarters.

Glenmark Life Sciences Limited (GLS.NS) Historical Enterprise Value (quarterly & annually)

How has GLS.NS Enterprise Value performed in the past?

The mean historical Enterprise Value of Glenmark Life Sciences Limited over the last ten years is 75.65B. The current 128.77B Enterprise Value has changed 16.92% with respect to the historical average. Over the past ten years (40 quarters), GLS.NS's Enterprise Value was at its highest in in the September 2024 quarter at 125.25B. The Enterprise Value was at its lowest in in the September 2020 quarter at 0.

Glenmark Life Sciences Limited (GLS.NS) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Glenmark Life Sciences Limited Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Glenmark Life Sciences Limited (GLS.NS) Average Enterprise Value

How has GLS.NS Enterprise Value performed in the past?

The current Enterprise Value of Glenmark Life Sciences Limited (GLS.NS) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Glenmark Life Sciences Limited (GLS.NS) Enterprise Value vs. Peers

How is GLS.NS’s Enterprise Value compared to its peers?

Glenmark Life Sciences Limited’s Enterprise Value is greater than Caplin Point Laboratories Limited (107.63B), greater than Novartis India Limited (13.50B), greater than Lincoln Pharmaceuticals Limited (12.73B), greater than Bafna Pharmaceuticals Limited (393.64M), greater than Vivimed Labs Ltd. (4.17B), greater than Ind-Swift Limited (8.90B), greater than Ind-Swift Limited (8.90B), greater than Parenteral Drugs (India) Ltd. (1.17B), greater than Ortin Laboratories Limited (159.91M), greater than Kovai Medical Center and Hospital Limited (68.64B),

Build a custom stock screener for Glenmark Life Sciences Limited (GLS.NS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Glenmark Life Sciences Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Glenmark Life Sciences Limited (GLS.NS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Glenmark Life Sciences Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.